文献速递肾血管病与高血压慢性肾脏病

闭塞性动脉粥样硬化性肾动脉狭窄远端人类肾脏的微血管重塑与血管生成信号改变

Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

研究纳入5例因肾血管闭塞行肾切除术的患者肾脏与7例无狭窄的废弃供肾(4例来自 deceased donors),采用微计算机断层扫描评估微血管空间密度与迂曲度,并行蛋白表达、基因表达与组织学检查。结果显示狭窄肾脏中等大小血管(0.2-0.3 mm)丢失(P=0.037)、微血管迂曲度增加,血管生成素-1、缺氧诱导因子-1α和凝血酶敏感蛋白-1蛋白表达升高而血管内皮生长因子蛋白表达降低,纤维化、管周毛细血管丢失和周细胞脱离更明显但新生管周毛细血管更多。结论认为人类肾动脉狭窄是主血管狭窄远端的微血管疾病,支持针对狭窄后肾脏微循环的治疗策略。

要点

  • 狭窄肾脏较供肾丢失0.2-0.3 mm中等大小血管(P=0.037)且微血管迂曲度增加。
  • 狭窄肾脏血管生成素-1、缺氧诱导因子-1α和凝血酶敏感蛋白-1蛋白表达升高,血管内皮生长因子蛋白表达降低。
  • 狭窄肾脏纤维化、管周毛细血管丢失和周细胞脱离更明显,但新生管周毛细血管更多。

核心结论

  • 研究量化了狭窄后人类肾脏显著的微血管重塑,肾动脉狭窄诱导肾微血管丢失、血管重塑和纤维化。
  • 尽管血管内皮生长因子下调,狭窄肾脏上调了与血管生成素-1相关的代偿性血管生成通路。
  • 这些观察强调人类肾动脉狭窄是主血管狭窄远端的微血管疾病,支持针对狭窄后肾脏微循环的治疗策略。

研究设计与样本

  • 研究纳入5例因肾血管闭塞行肾切除术的患者和7例无狭窄的废弃供肾(其中4例来自 deceased donors)。
  • 采用微计算机断层扫描评估微血管空间密度和迂曲度(微血管不成熟指数)。
  • 采用免疫印迹、聚合酶链反应和染色在体外研究肾脏蛋白表达、基因表达和组织学。

主要发现

  • 狭窄肾脏较供肾丢失0.2-0.3 mm中等大小血管(P=0.037)且微血管迂曲度增加。
  • 狭窄肾脏血管生成素-1、缺氧诱导因子-1α和凝血酶敏感蛋白-1蛋白表达高于供肾,血管内皮生长因子蛋白表达低于供肾。
  • 狭窄肾脏纤维化、管周毛细血管丢失和周细胞脱离较供肾更明显,但新生管周毛细血管多于供肾。

临床怎么用

  • 原文结论支持针对肾动脉狭窄患者狭窄后肾脏微循环的治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal artery stenosis (RAS) is an important cause of chronic kidney disease and secondary hypertension. In animal models, renal ischemia leads to downregulation of growth factor expression and loss of intrarenal microcirculation. However, little is known about the sequelae of large-vessel occlusive disease on the microcirculation within human kidneys. METHOD: This study included five patients who underwent nephrectomy due to renovascular occlusion and seven nonstenotic discarded donor kidneys (four deceased donors). Micro-computed tomography was performed to assess microvascular spatial densities and tortuosity, an index of microvascular immaturity. Renal protein expression, gene expression and histology were studied in vitro using immunoblotting, polymerase chain reaction and staining. RESULTS: RAS demonstrated a loss of medium-sized vessels (0.2-0.3 mm) compared with donor kidneys (P = 0.037) and increased microvascular tortuosity. RAS kidneys had greater protein expression of angiopoietin-1, hypoxia-inducible factor-1α and thrombospondin-1 but lower protein expression of vascular endothelial growth factor (VEGF) than donor kidneys. Renal fibrosis, loss of peritubular capillaries (PTCs) and pericyte detachment were greater in RAS, yet they had more newly formed PTCs than donor kidneys. Therefore, our study quantified significant microvascular remodeling in the poststenotic human kidney. RAS induced renal microvascular loss, vascular remodeling and fibrosis. Despite downregulated VEGF, stenotic kidneys upregulated compensatory angiogenic pathways related to angiopoietin-1. CONCLUSIONS: These observations underscore the nature of human RAS as a microvascular disease distal to main vessel stenosis and support therapeutic strategies directly targeting the poststenotic kidney microcirculation in patients with RAS.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Klomjit N, Zhu XY, Eirin A, et al. Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2022. PMID: 35451482. doi:10.1093/ndt/gfac156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。